Yale School of Medicine
New Haven, Connecticut, 06511, United States
NCT Number: NCT07071415
This is a survey-based study using an online panel. The goal of the study is to understand whether information about overdiagnosis influences breast cancer screening intention among older women. Participants are first asked a series of questions about breast cancer screening including their intention to continue screening, knowledge of screening, and beliefs about screening. They are then shown one of three videos about breast cancer screening that contain information about overdiagnosis or a fourth control video that is identical but contains no information about overdiagnosis. Participants are then again asked about screening intention, along with knowledge of screening, overdiagnosis, and questions around trust.
Looking for future studies?
Notify Me70 year and older
Female
Interventional
Not applicable
New Haven, Connecticut, 06511, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants in this study will view a video-based decision aid that describes the risks and benefits of breast cancer screening for older women. Participants assigned to the low risk of overdiagnosis arm will view a version of the decision aid the describes a low risk of overdiagnosis.
Participants in this study will view a video-based decision aid that describes the risks and benefits of breast cancer screening for older women. Participants assigned to the moderate risk of overdiagnosis arm will view a version of the decision aid the describes a moderate risk of overdiagnosis.
Participants in this study will view a video-based decision aid that describes the risks and benefits of breast cancer screening for older women. Participants assigned to the high risk of overdiagnosis arm will view a version of the decision aid the describes a high risk of overdiagnosis.
Participants in this study will view a video-based decision aid that describes the risks and benefits of breast cancer screening for older women. Participants assigned to the control arm will view a version of the decision aid that does not contain any information about overdiagnosis.
Time frame: Day 1
Intention to screen, measured on a 15 point scale. Total score range 1-15, lower score means less likely to screen.
Time frame: Day 1
Knowledge of screening will be quantified as the proportion of correct answers out of a total possible 7 questions in the pre test and 11 questions in the post test.
Time frame: Day 1
Understanding of overdiagnosis will be quantified as proportion of correct responses out of 3 questions about overdiagnosis.
Yale University
Other
Breast Cancer Screening Decision Aid
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07515846
Decision Aid, Geriatrics
New Haven, Connecticut, United States
View Trial DetailsNCT06296927
Anxiety, Anxiety Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05444725
Behavior, Breast Cancer Female
Aarhus, Denmark
View Trial DetailsNCT04509063
Behavior, Breast Diseases
Aarhus, Denmark
View Trial Details